̽»¨¾«Ñ¡

Farmakologisk kväveoxidforskning – Jon Lundbergs forskargrupp

Forskningen i vår grupp syftar till att utforska den fysiologiska och terapeutiska betydelsen av en alternativ bildningsväg för signalsubstansen kvävemonoxid (NO) som vi funnit.

Our Research

Recent studies show that the supposedly inert inorganic anions nitrate (NO³¯) and nitrite (NO²¯) can recycle in vivo to form nitric oxide (NO) and other bioactive nitrogen oxides. This represents an important alternative source of NO, especially during hypoxia when the classical L-arginine/NO synthase pathway may be dysfunctional.

A picture is now emerging suggesting important biological functions of the nitrate-nitrite-NO pathway, with provocative implications in relation to diet and cardiovascular homeostasis.

In addition, an expanding number of studies suggest a therapeutic potential for nitrate and nitrite in diseases such as myocardial infarction, stroke, systemic and pulmonary hypertension and gastric ulceration.

Projects

  • Nitrate and nitrite as a substrate for NO generation
  • Airway nitric oxide
  • NO and the gastrointestinal system
  • NO as a marker for inflammation
  • Antibacterial effects of nitrite.

Methods

We use most of the standard molecular biology techniques.

In addition, we have numerous highly specialised assays for determination of nitric oxide (NO) in vivo and in vitro. These include chemiluminescence detection of NO in exhaled breath, in nasal air and in intestinal gases (colon, stomach), as well as highly sensitive assays for nitrate, nitrite and S-nitrosothiols, citrulline assay, cGMP RIA, and immunohistochemistry for NOSs.

Collaborations

We collaborate with the research group Nitrate-nitrite-NO pathway in health and disease

Publikationer

Utvalda publikationer

  • Article: FREE RADICAL BIOLOGY AND MEDICINE. 2012;52(3):683-692
    Jadert C; Petersson J; Massena S; Ahl D; Grapensparr L; Holm L; Lundberg JO; Phillipson M
  • Article: FREE RADICAL BIOLOGY AND MEDICINE. 2012;52(3):693-698
    Rocha BS; Gago B; Barbosa RM; Lundberg JO; Radi R; Laranjinha J
  • Editorial comment: JOURNAL OF PHYSIOLOGY. 2011;589(22):5333-5334
    Weitzberg E; Lundberg JO
  • Letter: JOURNAL OF APPLIED PHYSIOLOGY. 2011;111(2):616-617
    Lundberg JO; Larsen FJ; Weitzberg E
  • Review: CURRENT DRUG TARGETS. 2011;12(9):1351-1363
    Rocha BS; Gago B; Pereira C; Barbosa RM; Bartesaghi S; Lundberg JO; Radi R; Laranjinha J
  • Article: EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 2011;41(8):889-897
    Malinovschi A; Henrohn D; Eriksson A; Lundberg JO; Alving K; Wikstrom G
  • Article: THE FASEB JOURNAL. 2011;25(8):2843-2852
    Larsen FJ; Schiffer TA; Sahlin K; Ekblom B; Weitzberg E; Lundberg JO
  • Article: NITRIC OXIDE - BIOLOGY AND CHEMISTRY. 2011;24(4):213-216
    Sioutas A; Gemzell-Danielsson K; Lundberg JO; Ehren I
  • Article: AMERICAN JOURNAL OF PHYSIOLOGY. HEART AND CIRCULATORY PHYSIOLOGY. 2011;300(4):H1174-H1181
    Gronros J; Jung C; Lundberg JO; Cerrato R; Ostenson C-G; Pernow J

Finansiering

  •  (VR)
  • (site in Swedish)
  • Distinguished Professor Award from ̽»¨¾«Ñ¡
  • (site in Swedish)

Medarbetare och kontakt

Gruppledare

Alla medarbetare i gruppen

Nyckelord:
Farmakologi och toxikologi Fysiologi Neurovetenskaper
JL
±õ²Ô²Ô±ð³óÃ¥±ô±ô²õ²µ°ù²¹²Ô²õ°ì²¹°ù±ð:
2024-04-10